{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T21:49:14Z","timestamp":1771710554101,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T00:00:00Z","timestamp":1406678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00280-014-2543-4","type":"journal-article","created":{"date-parts":[[2014,7,29]],"date-time":"2014-07-29T12:44:32Z","timestamp":1406637872000},"page":"699-709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study"],"prefix":"10.1007","volume":"74","author":[{"given":"Shogo","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuro","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Taura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Ajiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigekazu","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Yanagimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyoshi","family":"Toyokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Terajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Ioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,30]]},"reference":[{"key":"2543_CR1","doi-asserted-by":"crossref","unstructured":"Yamanaka K, Hatano E, Kanai M, Tanaka S, Yamamoto K, Narita M, Nagata H, Ishii T, Machimoto T, Taura K, Uemoto S (2014) A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer. Int J Clin Oncol 19(3):485\u2013489","DOI":"10.1007\/s10147-013-0578-x"},{"issue":"5","key":"2543_CR2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jso.21971","volume":"104","author":"S Kobayashi","year":"2011","unstructured":"Kobayashi S, Nagano H, Marubashi S, Wada H, Eguchi H, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M (2011) Treatment of borderline cases for curative resection of biliary tract cancer. J Surg Oncol 104(5):499\u2013503","journal-title":"J Surg Oncol"},{"key":"2543_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00534-008-0015-0","volume":"16","author":"S Miyakawa","year":"2009","unstructured":"Miyakawa S, Ishihara S, Horiguchi A, Takada T, Miyazaki M, Nagakawa T (2009) Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan. J Hepatobiliary Pancreat Surg 16:1\u20137","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"6","key":"2543_CR4","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s00268-007-9001-y","volume":"31","author":"S Hasegawa","year":"2007","unstructured":"Hasegawa S, Ikai I, Fujii H, Hatano E, Shimahara Y (2007) Surgical resection of hilar cholangiocarcinoma. Analysis of survival and postoperative complications. World J Surg 31(6):1256\u20131263","journal-title":"World J Surg"},{"issue":"8","key":"2543_CR5","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","volume":"95","author":"T Takada","year":"2002","unstructured":"Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T, Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95(8):1685\u20131695","journal-title":"Cancer"},{"issue":"8","key":"2543_CR6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jso.21409","volume":"100","author":"S Kobayashi","year":"2009","unstructured":"Kobayashi S, Nagano H, Marubashi S, Takeda Y, Tanemura M, Konishi K, Yoshioka Y, Inoue T, Doki Y, Mori M (2009) Impact of postoperative irradiation after non-curative resection of hilar biliary cancer. J Surg Oncol 100(8):657\u2013662","journal-title":"J Surg Oncol"},{"issue":"2","key":"2543_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2012.7352","volume":"308","author":"JP Neoptolemos","year":"2012","unstructured":"Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, Carter R, Tebbutt NC, Dervenis C, Smith D, Glimelius B, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Ghaneh P, Halloran CM, Lerch MM, Ol\u00e1h A, Rawcliffe CL, Verbeke CS, Campbell F, B\u00fcchler MW, European Study Group for Pancreatic Cancer (2012) Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA 308(2):147\u2013156","journal-title":"JAMA"},{"key":"2543_CR8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4236\/jct.2011.25095","volume":"2","author":"S Kobayashi","year":"2011","unstructured":"Kobayashi S, Miyamoto A, Shimizu J, Kashiwazaki M, Takeda Y, Ueshima S, Kim Y, Kitagawa T, Dono K, Mori M, Doki Y, Nagano H (2011) Comparison of 4-weekly vs 3-weekly gemcitabine as adjuvant chemotherapy following curative resection for biliary tract cancer: a prospective randomized controlled trial. J Cancer Ther 2:703\u2013709","journal-title":"J Cancer Ther"},{"issue":"3","key":"2543_CR9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jjco\/hym178","volume":"38","author":"A Maeda","year":"2008","unstructured":"Maeda A, Boku N, Fukutomi A, Kondo S, Kinoshita T, Nagino M, Uesaka K (2008) Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 in patients with resected pancreatic cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01). Jpn J Clin Oncol 38(3):227\u2013229","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"2543_CR10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.bjc.6605256","volume":"101","author":"H Ueno","year":"2009","unstructured":"Ueno H, Kosuge T, Matsuyama Y, Yamamoto J, Nakao A, Egawa S, Doi R, Monden M, Hatori T, Tanaka M, Shimada M, Kanemitsu K (2009) A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer 101(6):908\u2013915","journal-title":"Br J Cancer"},{"issue":"3","key":"2543_CR11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.297.3.267","volume":"297","author":"H Oettle","year":"2007","unstructured":"Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297(3):267\u2013277","journal-title":"JAMA"},{"issue":"9","key":"2543_CR12","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/cas.12218","volume":"104","author":"C Morizane","year":"2013","unstructured":"Morizane C, Okusaka T, Mizusawa J, Takashima A, Ueno M, Ikeda M, Hamamoto Y, Ishii H, Boku N, Furuse J (2013) Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805). Cancer Sci 104(9):1211\u20131216","journal-title":"Cancer Sci"},{"issue":"5","key":"2543_CR13","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00280-013-2106-0","volume":"71","author":"E Suzuki","year":"2013","unstructured":"Suzuki E, Ikeda M, Okusaka T, Nakamori S, Ohkawa S, Nagakawa T, Boku N, Yanagimoto H, Sato T, Furuse J (2013) A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer. Cancer Chemother Pharmacol 71(5):1141\u20131146","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"2543_CR14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00534-011-0499-x","volume":"19","author":"M Konishi","year":"2012","unstructured":"Konishi M (2012) Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction. J Hepatobiliary Pancreat Sci 19(4):301\u2013305","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"3","key":"2543_CR15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1365-182X(17)30755-4","volume":"2","author":"J Belghiti","year":"2000","unstructured":"Belghiti J, Clavien PA, Gadzijev E, Garden JO, Lau WY, Makuuchi M, Strong RW (2000) The Brisbane 2000 terminology of liver anatomy and resections. HPB 2(3):333\u2013339","journal-title":"HPB"},{"key":"2543_CR16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2307\/2531628","volume":"46","author":"J O\u2019Quigley","year":"1990","unstructured":"O\u2019Quigley J, Pepe M, Fisher L (1990) Continual reassessment method: a practical design for phase 1 clinical trials in cancer. Biometrics 46:33\u201348","journal-title":"Biometrics"},{"issue":"12","key":"2543_CR17","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/1097-0142(20010615)91:12<2378::AID-CNCR1271>3.0.CO;2-2","volume":"91","author":"T Ono","year":"2001","unstructured":"Ono T, Yamanoi A, Nazmy El Assal O, Kohno H, Nagasue N (2001) Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials. Cancer 91(12):2378\u20132385","journal-title":"Cancer"},{"issue":"2","key":"2543_CR18","first-page":"183","volume":"133","author":"EC Lai","year":"1998","unstructured":"Lai EC, Lo CM, Fan ST, Liu CL, Wong J (1998) Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg 133(2):183\u2013188","journal-title":"Arch Surg"},{"issue":"4","key":"2543_CR19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/hep.21341","volume":"44","author":"K Hasegawa","year":"2006","unstructured":"Hasegawa K, Takayama T, Ijichi M, Matsuyama Y, Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M (2006) Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. Hepatology 44(4):891\u2013895","journal-title":"Hepatology"},{"issue":"6","key":"2543_CR20","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/SLA.0b013e3181b0fc8b","volume":"250","author":"Y Murakami","year":"2009","unstructured":"Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H, Nakashima A, Sueda T (2009) Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. Ann Surg 250(6):950\u2013956","journal-title":"Ann Surg"},{"issue":"8","key":"2543_CR21","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1007\/s11605-009-0900-0","volume":"13","author":"Y Murakami","year":"2009","unstructured":"Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H, Nakashima A, Sueda T (2009) Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg 13(8):1470\u20131479","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"2543_CR22","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00280-013-2311-x","volume":"72","author":"S Kobayashi","year":"2013","unstructured":"Kobayashi S, Wada H, Hama N, Akita H, Kawamoto K, Eguchi H, Umeshita K, Doki Y, Mori M, Nagano H (2013) Evaluation of safety parameters and changes of serum concentration in liver transplant recipients treated with doxorubicin during the anhepatic period. Cancer Chemother Pharmacol 72(6):1325\u20131333","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"2543_CR23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s002800050687","volume":"40","author":"Y Ku","year":"1997","unstructured":"Ku Y, Kusunoki N, Kitagawa T, Maeda I, Fukumoto T, Iwasaki T et al (1997) Pharmacokinetics of adriamycin and cisplatin for anhepatic chemotherapy during liver transplantation. Cancer Chemother Pharmacol 40(6):457\u2013462","journal-title":"Cancer Chemother Pharmacol"},{"issue":"Suppl 1","key":"2543_CR24","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1111\/j.1432-2277.1996.tb01582.x","volume":"9","author":"T Kitagawa","year":"1996","unstructured":"Kitagawa T, Ku Y, Kusunoki N, Tominaga M, Maeda I, Fukumoto T et al (1996) Pharmacokinetics of intravenous adriamycin for anhepatic chemotherapy during liver transplantation. Transpl Int 9(Suppl 1):S105\u2013S108","journal-title":"Transpl Int"},{"issue":"4","key":"2543_CR25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00534-011-0494-2","volume":"19","author":"J Furuse","year":"2012","unstructured":"Furuse J, Kasuga A, Takasu A, Kitamura H, Nagashima F (2012) Role of chemotherapy in treatments for biliary tract cancer. J Hepatobiliary Pancreat Sci 19(4):337\u2013341","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2543_CR26","doi-asserted-by":"crossref","unstructured":"Bridgewater JA, Stubbs C, Stocken DD, Fox RP, Primrose JN (2011) BILCAP: A randomized clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following curative surgery for biliary tract cancers. J Clin Oncol Abstr 4125","DOI":"10.1200\/jco.2011.29.15_suppl.4125"},{"issue":"7","key":"2543_CR27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4251\/wjgo.v5.i7.171","volume":"5","author":"N Ram\u00edrez-Merino","year":"2013","unstructured":"Ram\u00edrez-Merino N, Aix SP, Cort\u00e9s-Funes H (2013) Chemotherapy for cholangiocarcinoma: an update. World J Gastrointest Oncol 5(7):171\u2013176","journal-title":"World J Gastrointest Oncol"},{"issue":"14","key":"2543_CR28","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J, ABC-02 Trial Investigators (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362(14):1273\u20131281","journal-title":"N Engl J Med"},{"issue":"6","key":"2543_CR29","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00280-014-2431-y","volume":"73","author":"M Toyoda","year":"2014","unstructured":"Toyoda M, Ajiki T, Fujiwara Y, Nagano H, Kobayashi S, Sakai D, Hatano E, Kanai M, Nakamori S, Miyamoto A, Tsuji A, Kaihara S, Ikoma H, Takemura S, Toyokawa H, Terajima H, Morita S, Ioka T (2014) Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004). Cancer Chemother Pharmacol 73(6):1295\u20131301","journal-title":"Cancer Chemother Pharmacol"},{"key":"2543_CR30","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/sim.4780141102","volume":"14","author":"SN Goodman","year":"1995","unstructured":"Goodman SN, Zahurak ML, Piantadosi S (1995) Some practical improvements in the continual reassessment method for phase I studies. Stat Med 14:1149\u20131161","journal-title":"Stat Med"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2543-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-014-2543-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2543-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T08:51:38Z","timestamp":1565686298000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-014-2543-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,30]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["2543"],"URL":"https:\/\/doi.org\/10.1007\/s00280-014-2543-4","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,30]]}}}